Task: Answer the multiple choice question.
Question: Which drug exhibits a 16.626% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1ccc(C(=O)OCC(=O)NCCC2=CCCCC2)s1
b O=C(CCS(=O)(=O)c1cccc2nsnc12)NCc1ccccc1Cl
Answer: b. O=C(CCS(=O)(=O)c1cccc2nsnc12)NCc1ccccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCS(=O)(=O)c1cccc2nsnc12)NCc1ccccc1Cl
O=C(CCS(=O)(=O)c1cccc2nsnc12)NCc1ccccc1Cl
3-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-[(2-chlorophenyl)methyl]propanamide